BioPharmSignal logoBioPharmSignal

Biotech News

PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study

PTC Therapeutics, Inc. (PTCT)PTC Therapeutics, Inc.Conference / presentation

WARREN, N.J., April 28, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webcast conference call today, April 28 at 4:30 p.m. ET to share results from the 24-month interim analysis of the PIVOT-HD long-term extension study of votoplam.

Open original release

Related news

PTCTPTC Therapeutics, Inc.2026-05-04 12:00 EST

PTC Therapeutics to Participate in Upcoming Investor Conferences

PTCTPTC Therapeutics, Inc.2026-02-23 13:00 EST

PTC Therapeutics to Participate at Upcoming Investor Conferences

TARAProtara Therapeutics2026-01-07 13:00 EST

Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

CAPRCapricor Therapeutics2026-03-12 13:00 EST

Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy

CAPRCapricor Therapeutics2026-02-24 14:00 EST

Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference

APLSApellis Pharmaceuticals2026-02-23 12:00 EST

Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference

APLSApellis Pharmaceuticals2026-01-05 12:00 EST

Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

BCRXBioCryst Pharmaceuticals2026-05-13 11:00 EST

BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026

KRYSKrystal Biotech2026-05-07 12:00 EST

Krystal Biotech to Present at BofA Securities 2026 Health Care Conference

BCRXBioCryst Pharmaceuticals2026-04-28 11:00 EST

BioCryst to Present at Upcoming Investor Conferences

View all latest news

PTC Therapeutics, Inc.

PTC Therapeutics is a biopharmaceutical company focused on rare disease and gene-related therapies. Its story combines commercial products with a pipeline aimed at genetically defined conditions.

Recent company news

PTCTPTC Therapeutics, Inc.2026-05-07 20:01 EST

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

PTCTPTC Therapeutics, Inc.2026-05-04 12:00 EST

PTC Therapeutics to Participate in Upcoming Investor Conferences

PTCTPTC Therapeutics, Inc.2026-04-28 20:05 EST

PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam

PTCTPTC Therapeutics, Inc.2026-04-28 13:28 EST

PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study

PTCTPTC Therapeutics, Inc.2026-04-22 12:00 EST

PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Stock data

Close
75.80 USD
Market cap
5.66B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States